140 related articles for article (PubMed ID: 37656097)
21. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
[TBL] [Abstract][Full Text] [Related]
22. Systolic Blood Pressure and Risk for Ventricular Arrhythmia in Patients With an Implantable Cardioverter Defibrillator.
Beinart R; Goldenberg I; Younis A; McNitt S; Huang D; Aktas MK; Spencer R; Kutyifa V; Nof E
Am J Cardiol; 2021 Mar; 143():74-79. PubMed ID: 33359194
[TBL] [Abstract][Full Text] [Related]
23. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
24. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
25. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
26. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks.
Miyazaki S; Taniguchi H; Kusa S; Komatsu Y; Ichihara N; Takagi T; Iwasawa J; Kuroi A; Nakamura H; Hachiya H; Hirao K; Iesaka Y
Europace; 2015 Feb; 17(2):289-94. PubMed ID: 25061229
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Frequency of Ventricular Tachyarrhythmia in Men-Versus-Women in Patients with Implantable Cardioverter-Defibrillator for Primary Prevention.
Ojo A; Younis A; Saxena S; Kutyifa V; Chen AY; McNitt S; Polonsky B; Aktas MK; Huang DT; Rosero S; Vidula H; Diamond A; Sampath R; Klein H; Steiner H; Zareba W; Goldenberg I
Am J Cardiol; 2022 Aug; 176():43-50. PubMed ID: 35606170
[TBL] [Abstract][Full Text] [Related]
28. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
30. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.
Sood N; Ruwald AC; Solomon S; Daubert JP; McNitt S; Polonsky B; Jons C; Clyne CA; Zareba W; Moss AJ
Eur Heart J; 2014 Jan; 35(2):106-15. PubMed ID: 24179073
[TBL] [Abstract][Full Text] [Related]
31. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).
Biton Y; Huang DT; Goldenberg I; Rosero S; Moss AJ; Kutyifa V; McNitt S; Strasberg B; Zareba W; Barsheshet A
Heart Rhythm; 2016 Apr; 13(4):888-93. PubMed ID: 26711799
[TBL] [Abstract][Full Text] [Related]
32. Comparable risk of recurrent ventricular tachyarrhythmias in implantable cardioverter-defibrillator recipients treated with single beta-blocker or combined amiodarone.
Schupp T; Behnes M; Kim SH; Müller J; Weidner K; Reiser L; Huseynov A; Bollow A; Borggrefe M; Taton G; Reichelt T; Ellguth D; Engelke N; Akin M; Große Meininghaus D; Bertsch T; Akin I
Basic Clin Pharmacol Toxicol; 2021 Mar; 128(3):493-502. PubMed ID: 33174309
[TBL] [Abstract][Full Text] [Related]
33. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
[TBL] [Abstract][Full Text] [Related]
34. Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT-RIT substudy.
Daimee UA; Vermilye K; Rosero S; Schuger CD; Daubert JP; Zareba W; McNitt S; Polonsky B; Moss AJ; Kutyifa V
Pacing Clin Electrophysiol; 2017 Dec; 40(12):1405-1411. PubMed ID: 29052236
[TBL] [Abstract][Full Text] [Related]
35. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
[TBL] [Abstract][Full Text] [Related]
36. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
[TBL] [Abstract][Full Text] [Related]
37. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis.
Kutyifa V; Daubert JP; Olshansky B; Huang DT; Zhang C; Ruwald AC; McNitt S; Zareba W; Moss AJ; Schuger C
Heart Rhythm; 2015 Sep; 12(9):2030-7. PubMed ID: 26001510
[TBL] [Abstract][Full Text] [Related]
38. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
[TBL] [Abstract][Full Text] [Related]
39. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
[TBL] [Abstract][Full Text] [Related]
40. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
